Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.
van der Weerd, Neelke C
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. [electronic resource] - PloS one 2012 - e39783 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0039783 doi
Aged
Antimicrobial Cationic Peptides--blood
Biomarkers--blood
C-Reactive Protein--metabolism
Cross-Sectional Studies
Erythropoiesis--drug effects
Erythropoietin--blood
Female
Ferritins--blood
Glomerular Filtration Rate--drug effects
Hematinics--therapeutic use
Hepcidins
Humans
Iron--metabolism
Kidney--drug effects
Kidney Failure, Chronic--blood
Male
Middle Aged
Peptide Fragments--blood
Renal Dialysis
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. [electronic resource] - PloS one 2012 - e39783 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0039783 doi
Aged
Antimicrobial Cationic Peptides--blood
Biomarkers--blood
C-Reactive Protein--metabolism
Cross-Sectional Studies
Erythropoiesis--drug effects
Erythropoietin--blood
Female
Ferritins--blood
Glomerular Filtration Rate--drug effects
Hematinics--therapeutic use
Hepcidins
Humans
Iron--metabolism
Kidney--drug effects
Kidney Failure, Chronic--blood
Male
Middle Aged
Peptide Fragments--blood
Renal Dialysis